Virtus ETF Advisers LLC Shattuck Labs, Inc. Transaction History

Virtus ETF Advisers LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$2.7 - $4.59 $50,074 - $85,126	-18,546 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$4.22 - $8.89 $4,650 - $9,796	-1,102 Reduced 5.61%	18,546 $79,000
Q4 2021 Feb 14, 2022	BUY	$8.36 - $21.08 $101,874 - $256,880	12,186 Added 163.31%	19,648 $167,000
Q3 2021 Nov 15, 2021	SELL	$17.57 - $28.95 $6,887 - $11,348	-392 Reduced 4.99%	7,462 $152,000
Q2 2021 Aug 10, 2021	BUY	$24.14 - $37.68 $189,595 - $295,938	7,854 New	7,854 $228,000

28.8M

300

1.2K

Ticker STTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,382,000
Market Cap $47M
Description
Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is ...

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Virtus ETF Advisers LLC with notifications on news.